Bafna Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended December 31, 2025.
BAFNAPH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bafna Pharmaceuticals has filed a routine compliance certificate with the stock exchanges for the October–December 2025 quarter. The certificate was issued by Cameo Corporate Services Limited, the company's Registrar and Share Transfer Agent, under SEBI's Depositories and Participants Regulations, 2018. It confirms that share dematerialisation requests received during the quarter were processed and confirmed with the depositories on time. It also confirms that physical share certificates received for demat were mutilated and cancelled, and the depositories' names were updated as the registered owners in the company's records.
This is a standard procedural filing with no impact on business, financials, or share price. It simply evidences that the company's share transfer and demat processes are functioning as required by SEBI regulations.